Skip to main content

Autoimmune & autoinflammatory

Raynaud's to scleroderma risk

Most Raynaud's is benign and stays that way - but a defined minority is the opening act of scleroderma, and two simple tests separate the groups years before anything else changes.

Key points

The essentials at a glance.

What to look out for, which tests matter, who treats it, and what usually happens next.

  • Primary Raynaud's: onset in the teens or twenties, symmetrical, no tissue damage, normal tests - excellent outlook

  • Warning features: onset after 35-40, severe or asymmetric attacks, finger ulcers or pitted scars, puffy fingers, heartburn

  • The two decisive tests: ANA (with scleroderma-specific antibodies) and nailfold capillaroscopy

  • Abnormal capillaries plus a scleroderma antibody carries a high risk of progression; both normal makes it very unlikely

  • Anyone with warning features deserves both tests - ask for them by name

Understanding it

About Raynaud's to scleroderma risk.

Raynaud's phenomenon - fingers blanching white then blue in the cold - affects millions and is usually an isolated quirk of circulation. In a small proportion, though, it is the earliest visible sign of systemic sclerosis, appearing years before skin changes. The transition risk is not guesswork: under a capillaroscope, the capillaries at the nail bed in early scleroderma become enlarged, distorted and drop out in a recognisable pattern, while blood tests can reveal anticentromere or anti-Scl-70 antibodies long before disease declares itself.

The stratification is powerful in both directions - normal capillaries with negative antibodies mean progression is rare and reassurance is evidence-based, while abnormalities identify the group who need active surveillance so that lung, heart and kidney complications are caught at their most treatable. This is one of the clearest examples in medicine of two cheap tests changing a decade of management, and yet capillaroscopy remains hard to access outside specialist units. In many parts of the UK, a routine NHS referral to the relevant specialist clinic currently means waiting many months - sometimes more than a year for the rarest conditions - whereas an initial appointment with a private consultant is typically available within around two weeks, with investigations arranged soon after.

Frequently asked

Common questions about Raynaud's to scleroderma risk.

Quick, plain-English answers to what people ask us most.

  • What is the link between Raynaud's and scleroderma?

    Most Raynaud's phenomenon - fingers or toes turning white, then blue, then red in the cold - is primary and entirely benign. A defined minority, however, is secondary Raynaud's, the first sign of an underlying condition such as scleroderma, and specific tests can identify this risk years before other changes appear.

  • What causes secondary Raynaud's linked to scleroderma?

    Secondary Raynaud's reflects small blood vessel changes that are part of the same disease process seen in scleroderma and related autoimmune conditions, rather than the simple, harmless vessel spasm of primary Raynaud's.

  • What tests distinguish benign Raynaud's from scleroderma risk?

    Two simple tests do most of the work: a blood test for specific autoantibodies (such as ANA and scleroderma-related antibodies) and nailfold capillaroscopy, which examines the tiny blood vessels at the base of the fingernail for characteristic changes.

  • What are the warning signs that Raynaud's might not be benign?

    Features that raise concern include onset after age 30, very severe or asymmetric attacks, skin thickening, difficulty swallowing, or digital ulcers, alongside abnormal antibody or capillaroscopy results.

  • Is Raynaud's dangerous?

    Primary Raynaud's, the vast majority of cases, is uncomfortable but not dangerous. Secondary Raynaud's linked to scleroderma needs monitoring because the underlying condition can affect other organs, though early identification allows this to be managed proactively.

  • How is Raynaud's treated?

    Management starts with keeping warm and avoiding triggers such as cold and smoking, and can progress to calcium channel blockers or other vasodilating medications for more troublesome symptoms, alongside treatment of any underlying condition if found.

  • Raynaud's vs scleroderma - what's the difference?

    Raynaud's is a symptom - the vessel spasm response to cold or stress - while scleroderma is a systemic autoimmune disease that can cause secondary Raynaud's as one of its earliest features, years before skin thickening or organ involvement develops.

  • When should I see a doctor about Raynaud's?

    See your GP if Raynaud's starts after age 30, is severe, or comes with other symptoms like skin changes or swallowing difficulty, so appropriate antibody and capillaroscopy testing can be arranged. A private rheumatologist can typically be seen within about two weeks for this assessment.